4.7 Article Proceedings Paper

APOBEC3B Deletion and Risk of HIV-1 Acquisition

期刊

JOURNAL OF INFECTIOUS DISEASES
卷 200, 期 7, 页码 1054-1058

出版社

OXFORD UNIV PRESS INC
DOI: 10.1086/605644

关键词

-

资金

  1. CCR NIH HHS [HHSN261200800001C] Funding Source: Medline
  2. Intramural NIH HHS [Z01 BC010798-02, ZIA BC010297-12, ZIA BC010297-14, Z99 CA999999, ZIA BC010297-15, ZIA BC010297-13, Z01 BC010297-11, Z01 BC010798-01, Z01 BC010297-10] Funding Source: Medline
  3. NCI NIH HHS [HHSN261200800001E, N02CP55504] Funding Source: Medline
  4. NIDA NIH HHS [R01 DA004334, R01-DA04334, R56 DA004334] Funding Source: Medline
  5. PHS HHS [R01-12586] Funding Source: Medline

向作者/读者索取更多资源

The human APOBEC3 family of cytidine deaminases provides intrinsic immunity to retroviral infection. A naturally occurring 29.5-kb deletion removes the entire APOBEC3B gene. We examined the impact of the APOBEC3B gene deletion in >4000 individuals from 5 human immunodeficiency virus type 1 (HIV-1) natural history cohorts. The hemizygous genotype had no effect on either acquisition of HIV-1 infection or progression to AIDS. However, the homozygous deletion was significantly associated with unfavorable outcomes for HIV-1 acquisition (odds ratio, 7.37; P = .024), progression to AIDS (relative hazard, 4.01; P = .03) and viral set point (P = .04). These findings suggest that the loss of APOPBEC3B may increase host susceptibility to HIV-1 acquisition and progression to AIDS and warrant further study.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据